CGEM Earnings

Quarterly EPS
$-0.69
Q3 2024
$-0.51
Q4 2024
$-0.74
Q1 2025
$-1.19
Q2 2025
$-0.86
Q3 2025
$-0.49
Q4 2025
$-0.75
Q1 2026
$-0.87
Q2 2026
Latest RevenueN/A
Latest Net Income-53704000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.870-53704000+26.9%
Q1 2026-$0.750-49661000-1.4%
Q4 2025-$0.490-50713000+3.9%
Q3 2025-$0.860-50610000-24.6%
Q2 2025-$1.190-70055000-58.7%
Q1 2025-$0.740-48501000+1.3%
Q4 2024-$0.510-47647000-410.0%
Q3 2024-$0.690-40560000+24.2%
Q2 2024-$0.750-42028000
Q1 2024-$0.750-37340000
Q4 2023-$0.100-25563000
Q3 2023-$0.910-39183000
Cullinan Therapeutics (CGEM) — Earnings